854. FDA
Session: Symposium: Susceptibility Breakpoints Controversies and Consensus
Saturday, October 23, 2010: 10:30 AM
Parkview Terrace / 1-3

Katherine Laessig, MD , Food and Drug Administration, Silver Spring, MD


K. Laessig, None

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 21 with the exception of research findings presented at IDSA press conferences.


Copyright IDSA 2009 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org